|
Sustained, target delivery for treatment of cervical pathologies
|
1R43CA162417-01A1
|
$253,110
|
|
Spencer, WENDY
|
3P BIOTECHNOLOGIES, INC.
|
|
Targeted Therapy for Non Small Cell Lung Carcinoma: In vivo Feasibility Studies
|
1R43CA162629-01A1
|
$193,879
|
|
Serrero, Ginette
|
A AND G PHARMACEUTICAL, INC.
|
|
SBIR Phase II, Topic 255: Development of Novel Anticancer Agent to Potentiate Se
|
N44CO140040-000
|
$1,478,552
|
$739,276
|
SERRERO, GINETTE
|
A&G PHARMACEUTICAL, INC
|
|
Ultrasound Ablation on Bone Cancer Under CT Fluoroscopy
|
5R44CA112852-05
|
$941,541
|
$94,154
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Prevention of Tumor Recurrence Following Surgical Resection (Phase II)
|
6R44CA135967-03
|
$498,107
|
|
Wolinsky, Jesse
|
ACUITYBIO CORPORATION
|
|
Developing Novel Therapies for Treating Breast-Cancer-Related Lymphedema
|
1R41CA183335-01
|
$225,000
|
$225,000
|
HSU, SHEAU-YU
|
ADEPTHERA, LLC
|
|
Automated Systems for Detection and Molecular Characterization of Circulating Tum
|
5R44CA122444-06
|
$979,021
|
$979,021
|
LUO, YULING
|
ADVANCED CELL DIAGNOSTICS, INC.
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
5R44CA124032-04
|
$1,917,582
|
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
SBIR Phase I Topic 328 Project Titled: ""Tumor-Micorenvironment-on Chip of Breas
|
N43CO140021-000
|
$208,489
|
$208,489
|
PARK, HAESUN
|
AKINA, INC.
|
|
Diffusion Weighted Breast MR Imaging for Screening Women with Dense Breasts
|
2R44CA186313-02
|
$798,404
|
$798,404
|
PENN, ALAN
|
ALAN PENN AND ASSOCIATES, INC.
|
|
The 3D whole Body Distribution of NIR transferrin using FRET tomography imaging
|
5R21CA161782-02
|
$199,576
|
$199,576
|
BARROSO, MARGARIDA
|
ALBANY MEDICAL COLLEGE
|
|
MOTILITY AND INVASION
|
5P01CA100324-10
|
$2,016,840
|
$2,016,840
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Targeted therapy of pancreatic cancer with in vivo radionuclide generator
|
5R21CA156088-02
|
$216,630
|
|
DADACHOVA, EKATERINA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S4
|
$3,757,417
|
$1,014,503
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S5
|
$249,999
|
$67,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S6
|
$249,999
|
$67,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S7
|
$75,000
|
$20,250
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Proton-coupled folate/antifolate transport
|
5R01CA082621-14
|
$513,291
|
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Targeting PML for therapy in leukemia-initiating cells
|
4R00CA139009-03
|
$249,000
|
|
ITO, KEISUKE
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Development of Novel Drugs to Alleviate CPT-11 Toxicity
|
1R01CA161879-01A1
|
$315,319
|
|
MANI, SRIDHAR
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Paul Calabresis Career Development Award For Clinical Oncology
|
5K12CA132783-04
|
$1,134,000
|
|
PEREZ-SOLER, ROMAN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
microRNA expression profiling of benign breast tissue and breast cancer risk
|
5R01CA142942-03
|
$738,155
|
$738,155
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
A Pilot Study of Positively Smoke Free on the Web (PSFW) for HIV-infected Smokers
|
5R21CA163100-02
|
$173,887
|
|
Shuter, Jonathan
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
5U10CA014958-38
|
$101,749
|
$2,035
|
Sparano, Joseph
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Role of the Sex Hormones and Insulin/IGF-Axes in Endometrial Cancer Recurrence
|
5R01CA133010-04
|
$395,050
|
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
MOTILITY AND INVASION
|
2P01CA100324-11A1
|
$2,028,990
|
$2,028,990
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Signal Transduction & Actin During Amoeboid Chemotaxis
|
5R01CA150344-26
|
$343,213
|
$343,213
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Tumor microenvironments determing migration, dissemination and dormancy
|
5U54CA163131-04
|
$862,508
|
$569,255
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Systems microscopy analysis of tumor cell motility in microenvironment context
|
5K99CA172360-02
|
$138,712
|
$138,712
|
GLIGORIJEVIC, BOJANA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
$19,500
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
$38,610
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$932,164
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Rac1 regulates protrusion and invasion of breast cancers in 3D
|
1R21CA181838-01A1
|
$181,613
|
$181,613
|
HODGSON, LOUIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Novel approach to study intravasation in primary human breast cancer cells(PQ24)
|
5R01CA170507-03
|
$341,989
|
$341,989
|
OKTAY, MAJA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The Metastatic Cascade: Macrophages Lead the Way
|
5R01CA172451-02
|
$426,219
|
$140,652
|
POLLARD, JEFFREY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
microRNA expression profiling of benign breast tissue and breast cancer risk
|
5R01CA142942-05
|
$569,377
|
$569,377
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
In Vivo Multiphoton Based Imaging of Complex Cancer Cell Behavior
|
5R01CA164468-04
|
$734,934
|
$514,454
|
VERKHUSHA, VLADISLAV
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The B7x pathway in the tumor microenvironment
|
1R01CA175495-01A1
|
$346,525
|
$86,631
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The B7x pathway in the tumor microenvironment
|
3R01CA175495-01A1S1
|
$59,075
|
$14,769
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Nemours Community Clinical Oncology Program
|
3U10CA176879-01S1
|
$89,460
|
$12,524
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
A Potent Small Molecule Chemokine Antagonist Blocks Tumor Cell Dissemination In V
|
1R43CA183362-01A1
|
$224,748
|
$112,374
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
Global Proteomic Screening by MALDI Spectrometric Imaging of Protein-Bead Arrays
|
5R43CA161965-02
|
$149,865
|
|
Lim, Mark
|
AMBERGEN, INC
|
|
Expression-Based Multi-Gene Signatures for CRC Recurrence and Chemoselection
|
5R44CA119565-07
|
$999,610
|
|
Sears, Christopher
|
AMBERGEN, INC
|
|
Adolescent Smoking Cessation in Pediatric Primary Care
|
5R01CA140576-03
|
$507,732
|
|
KLEIN, JONATHAN
|
AMERICAN ACADEMY OF PEDIATRICS
|
|
Community Clinical Oncology Program
|
5U10CA037422-25
|
$4,499,349
|
$809,883
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-36S1
|
$172,284
|
$13,783
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-36
|
$12,915,055
|
$1,033,204
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Online Social Networks for Dissemination of Smoking Cessation Interventions
|
5R01CA155369-02
|
$373,125
|
|
Cobb, Nathan
|
AMERICAN LEGACY FOUNDATION
|
|
Improving Adherence to Web-based Cessation Programs: A Social Network Approach
|
5R01CA155489-02
|
$506,969
|
|
GRAHAM, AMANDA
|
AMERICAN LEGACY FOUNDATION
|
|
2014 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA186413-01
|
$2,500
|
$825
|
LUSCINSKAS, FRANCIS
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
Total relevant funding to Breast for this search: $810,621,175
|